Incidence and progression of diabetic retinopathy in patients treated with glucagon-like peptide-1 receptor agonists versus sodium-glucose cotransporter 2 inhibitors: A population-based cohort study.

Donna Shu-Han LinHao-Yun LoKuan-Chih HuangTing-Tse LinJen-Kuang LeeLian-Yu Lin

Published in: Diabetes, obesity & metabolism (2024)

In patients with diabetes mellitus and established DR, GLP1RA treatment was associated with increased risks of DR progression compared with SGLT2i use.

Keyphrases

diabetic retinopathy
optical coherence tomography
editorial comment
rheumatoid arthritis
risk factors
human health
type diabetes
disease activity
ankylosing spondylitis
risk assessment
combination therapy
climate change
glycemic control
insulin resistance
weight loss
idiopathic pulmonary fibrosis